7579 related articles for article (PubMed ID: 1934088)
1. Patterns of antigenic expression of human glioma cells.
McKeever PE; Davenport RD; Shakui P
Crit Rev Neurobiol; 1991; 6(2):119-47. PubMed ID: 1934088
[TBL] [Abstract][Full Text] [Related]
2. Products of cells cultured from gliomas. VI. Immunofluorescent, morphometric, and ultrastructural characterization of two different cell types growing from explants of human gliomas.
McKeever PE; Smith BH; Taren JA; Wahl RL; Kornblith PL; Chronwall BM
Am J Pathol; 1987 May; 127(2):358-72. PubMed ID: 3555104
[TBL] [Abstract][Full Text] [Related]
3. Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody.
Bourdon MA; Wikstrand CJ; Furthmayr H; Matthews TJ; Bigner DD
Cancer Res; 1983 Jun; 43(6):2796-805. PubMed ID: 6342760
[TBL] [Abstract][Full Text] [Related]
4. Products of cells cultured from gliomas. VII. Extracellular matrix proteins of gliomas which contain glial fibrillary acidic protein.
McKeever PE; Fligiel SE; Varani J; Castle RL; Hood TW
Lab Invest; 1989 Feb; 60(2):286-95. PubMed ID: 2464718
[TBL] [Abstract][Full Text] [Related]
5. Common antigenic determinants on human melanoma, glioma, neuroblastoma, and sarcoma cells defined with monoclonal antibodies.
Seeger RC; Rosenblatt HM; Imai K; Ferrone S
Cancer Res; 1981 Jul; 41(7):2714-7. PubMed ID: 6166367
[TBL] [Abstract][Full Text] [Related]
6. Cellular antitumor immune response to a branched lysine multiple antigenic peptide containing epitopes of a common tumor-specific antigen in a rat glioma model.
Ciesielski MJ; Kazim AL; Barth RF; Fenstermaker RA
Cancer Immunol Immunother; 2005 Feb; 54(2):107-19. PubMed ID: 15340764
[TBL] [Abstract][Full Text] [Related]
7. Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo.
Laterra J; Nam M; Rosen E; Rao JS; Lamszus K; Goldberg ID; Johnston P
Lab Invest; 1997 Apr; 76(4):565-77. PubMed ID: 9111517
[TBL] [Abstract][Full Text] [Related]
8. The biology of malignant gliomas--a comprehensive survey.
McComb RD; Bigner DD
Clin Neuropathol; 1984; 3(3):93-106. PubMed ID: 6205806
[TBL] [Abstract][Full Text] [Related]
9. Antigenic heterogeneity of human brain tumors defined by monoclonal antibodies.
Stavrou D; Bise K; Groeneveld J; Stocker U; Kretzschmar HA; Keiditsch E; Mehraein P
Anticancer Res; 1989; 9(6):1489-96. PubMed ID: 2697177
[TBL] [Abstract][Full Text] [Related]
10. Cellular differentiation and expression of matrix genes in type 1 neurofibromatosis.
Peltonen J; Jaakkola S; Lebwohl M; Renvall S; Risteli L; Virtanen I; Uitto J
Lab Invest; 1988 Dec; 59(6):760-71. PubMed ID: 2462129
[TBL] [Abstract][Full Text] [Related]
11. Expression of complement membrane regulators membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59) in human malignant gliomas.
Mäenpää A; Junnikkala S; Hakulinen J; Timonen T; Meri S
Am J Pathol; 1996 Apr; 148(4):1139-52. PubMed ID: 8644856
[TBL] [Abstract][Full Text] [Related]
12. Role of high molecular weight extracellular matrix proteins in glioma cell migration.
Mahesparan R; Tysnes BB; Edvardsen K; Haugeland HK; Cabrera IG; Lund-Johansen M; Engebraaten O; Bjerkvig R
Neuropathol Appl Neurobiol; 1997 Apr; 23(2):102-12. PubMed ID: 9160895
[TBL] [Abstract][Full Text] [Related]
13. Biological and karyotypic characterization of a new cell line derived from human gliosarcoma.
Westphal M; Haensel M; Mueller D; Laas R; Kunzmann R; Rohde E; Koenig A; Hoelzel F; Herrmann HD
Cancer Res; 1988 Feb; 48(3):731-40. PubMed ID: 3275500
[TBL] [Abstract][Full Text] [Related]
14. Production and characterization of two human glioma xenograft-localizing monoclonal antibodies.
Wikstrand CJ; McLendon RE; Bullard DE; Fredman P; Svennerholm L; Bigner DD
Cancer Res; 1986 Nov; 46(11):5933-40. PubMed ID: 3756930
[TBL] [Abstract][Full Text] [Related]
15. Immune selection in murine tumors. Ph.d thesis.
Svane IM; Engel AM
APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
[TBL] [Abstract][Full Text] [Related]
16. Antigen variation in a human glioblastoma: from the primary tumor to the second recurrence, permanent cell line and xenotransplantation tumors.
Bilzer T; Stavrou D; Wechsler W; Wöhler B; Keiditsch E
Anticancer Res; 1991; 11(2):547-53. PubMed ID: 2064311
[TBL] [Abstract][Full Text] [Related]
17. Human glioma-associated antigens detected by monoclonal antibodies.
Schnegg JF; Diserens AC; Carrel S; Accolla RS; de Tribolet N
Cancer Res; 1981 Mar; 41(3):1209-13. PubMed ID: 7459861
[TBL] [Abstract][Full Text] [Related]
18. Tumor antigens in astrocytic gliomas.
Kurpad SN; Zhao XG; Wikstrand CJ; Batra SK; McLendon RE; Bigner DD
Glia; 1995 Nov; 15(3):244-56. PubMed ID: 8586461
[TBL] [Abstract][Full Text] [Related]
19. Aspects of immunobiology and immunotherapy and uses of monoclonal antibodies and biologic immune modifiers in human gliomas.
Lee Y; Bigner DD
Neurol Clin; 1985 Nov; 3(4):901-17. PubMed ID: 2417097
[TBL] [Abstract][Full Text] [Related]
20. Gene expression of neural cell adhesion molecule L1 in malignant gliomas and biological significance of L1 in glioma invasion.
Izumoto S; Ohnishi T; Arita N; Hiraga S; Taki T; Hayakawa T
Cancer Res; 1996 Mar; 56(6):1440-4. PubMed ID: 8640837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
